Back
Century Aluminum 10K Form
Buy
61
CENX
Century Aluminum
Last Price:
17.52
Seasonality Move:
23.2%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-01 | 10Q | CENX/Century Aluminum Quarterly |
2024-03-15 | 10K | CENX/Century Aluminum Annual |
2023-11-08 | 10Q | CENX/Century Aluminum Quarterly |
2023-08-09 | 10Q | CENX/Century Aluminum Quarterly |
2023-05-09 | 10Q | CENX/Century Aluminum Quarterly |
2023-02-27 | 10K | CENX/Century Aluminum Annual |
Receive CENX News And Ratings
See the #1 stock for the next 7 days that we like better than CENX
CENX Financial Statistics
Sales & Book Value
Annual Sales: | $2.19B |
---|---|
Cash Flow: | $-5.4M |
Price / Cash Flow: | 0 |
Annual Sales: | $6.49 |
Price / Book: | 2.71 |
Profitability
EPS (TTM): | 2.08000 |
---|---|
Net Income (TTM): | $232.3M |
Gross Margin: | $91.9M |
Return on Equity: | 50.38% |
Return on Assets: | 12.89% |
Century Aluminum Earnings Forecast
Key Century Aluminum Financial Ratios
- The Gross Profit Margin over the past 28 years for CENX is 4.21%.
- The Selling, General & Administrative Expenses for CENX have been equal to 2.03% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is -82.37% of Operating Income.
- The Net Earning history of CENX is -1.97% of Total Revenues.
- Per Share Earnings over the last 28 years have been positive in 10 years.
Century Aluminum Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Metals & Mining |
Sector: | Materials |
Current Symbol: | CENX |
CUSIP: | 156431 |
Website: | centuryaluminum.com |
Debt
Debt-to-Equity Ratio: | 0.8 |
---|---|
Current Ratio: | 1.72 |
Quick Ratio: | 0.57 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 22.12 |
CENX Technical Analysis vs Fundamental Analysis
Buy
61
Century Aluminum (CENX)
is a Buy
Is Century Aluminum a Buy or a Sell?
-
Century Aluminum stock is rated a Buy
The current Century Aluminum [CENX] share price is $17.55. The Score for CENX is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.